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Membranous webWe have identiﬁed a membrane-active region in the HCV NS4B protein by studying membrane rupture
induced by a NS4B-derived peptide library on model membranes. This segment corresponds to one of two
previously predicted amphipathic helix and deﬁne it as a new membrane association domain. We report the
binding and interaction with model membranes of a peptide patterned after this segment, peptide NS4BH2,
and show that NS4BH2 strongly partitions into phospholipid membranes, interacts with them, and is located
in a shallow position in the membrane. Furthermore, changes in the primary sequence cause the disruption
of the hydrophobicity along the structure and prevent the resulting peptide from interacting with the
membrane. Our results suggest that the region where the NS4BH2 is located might have an essential role in
the membrane replication and/or assembly of the viral particle through the modulation of the replication
complex. Our ﬁndings therefore identify an important region in the HCV NS4B protein which might be
implicated in the HCV life cycle and possibly in the formation of the membranous web.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV), an enveloped positive single-stranded
RNA virus included in the genus Hepacivirus, family Flaviviridae, is a
major cause of liver disease. With approximately 170 to 200 million
people infected worldwide [1,2] and no protective vaccine available at
present, this disease has emerged as a serious global health problem
since the virus was ﬁrst identiﬁed [3,4]. HCV has a single-stranded
genome which encodes a polyprotein of about 3010 amino acids. HCV
entry into the host cell is achieved by the fusion of viral and cellular
membranes, and the morphogenesis has been suggested to take place
in the endoplasmic reticulum [5]. The structural proteins are located
in the N-terminal part of the polyprotein and the non-structural
proteins (NS) in the latter part [6]. The variability of the HCV proteinsositol; BPS, Bovine brain L-α-
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ll rights reserved.gives the virus the ability to escape the host immune surveillance
system and notably hampers the development of an efﬁcient vaccine.
Details about HCV replication process remain largely unclear, but it
is generally believed that most of the NS proteins are involved. The fact
that all NS proteins are localized together with newly synthesized viral
RNA on the endoplasmic reticulum (ER) or membranes originating
from it [7–9] supports this hypothesis. Most NS proteins also interact
with several other NS proteins, and some of them interact with all [10].
The non-structural proteins include two viral proteases, NS2 and NS3,
responsible for the maturation of all the NS proteins [11]. The NS4A
protein serves as a cofactor for NS3 and is incorporated as an integral
component into the enzyme core. NS3 is a multifunctional proteinwith
a RNA helicase/NTPase domain apart from the serine protease domain
[12–14]. NS5A is a phosphoprotein of unknown function, but is indis-
pensable for replication and was suggested to be involved in interferon
resistance [15–17]. The NS5B RNA-dependent RNA polymerase is the
catalytic subunit of the viral replication complex [18–20].
The NS4B protein is a highly hydrophobic poorly characterized
protein. Immunoﬂuorescence analyses and subcellular fractionation
experiments indicate that NS4B is associated with membranes of the
ER or an ER-derived modiﬁed compartment [21]. It has recently been
shown that NS4B is palmitoylated in the C-terminal region of the
protein and its N-terminal cytoplasmic region has potent polymeriza-
tion activity [22]. NS4B is also engaged in virus assembly and release
[23]. Interestingly, the expression of NS4B induces the formation of
intracellular membrane changes that are visible by electron micro-
scopy, the so called membranous web [24]. This membranous web has
been postulated to be the HCV RNA replication complex. Thus, a
function of NS4B might be to induce a speciﬁc membrane alteration
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complex and therefore has a critical role in the HCV cycle. Due to the
high hydrophobic nature of NS4B, a detailed structure determination
of this protein using experimental techniques will not be obtained in
the near future. Computer analyses and experimental data based on
glycosylation mapping predicted four to ﬁve transmembrane domains
in the NS4B protein with the N terminus in the lumen and the C
terminus in the cytoplasm [21,25,26] (see Fig. 1A). The model
proposes two conformational states of the N-terminal tail of NS4B,
an orientation towards the cytoplasm and a translocation of the NS4B
N terminus across the ER membrane with the formation of a ﬁfth
transmembrane domainwith the N terminus probably located around
amino acid 60 [27]. This translocation occurs in all genotypes and can
be associated with the membrane-changing capacity of NS4B [27].
Therefore NS4B is likely to be anchored to the membrane and be an
integral membrane protein [21]. The C-terminal part of NS4B reveals
signiﬁcant similarities throughout all investigated viruses of the Fla-
viviridae family. Two α-helical elements have been predicted, the ﬁrst
α-helix (H1) being 13 residues in length (approximately from amino
acid 1912 to 1924) and the second α-helix (H2) comprising 23
residues (approximately from amino acid 1940 to 1963) pointing out
to a yet unknown common function of the C-terminal globular part in
Flaviviridae [28]. Interestingly, mutations in H2 abolish replication
[23,29].Fig. 1. (A) Hydrophobicmoment, hydrophobicity and interfacial hydrophobicity distribution of
regions, according to literature consensus [23,25,28] are also shown: ﬁve proposed transmemb
NS4B derived peptide librarywith sequence andmembrane leakage elicited by the peptide libra
and a complex lipid composition resembling the ER membrane (upper and lower histograms,
(C) Sequences and hydrophobic moments of the peptides NS4BH2, SC1 and SC2, used in this stWe have recently identiﬁed the membrane-active regions of a
number of viral proteins by observing the effect of glycoprotein-
derived peptide libraries on model membrane integrity [30–34].
These results allowed us to propose the location of different segments
in these proteins that are implicated in protein–lipid and protein–
protein interactions. These studies have helped us to understand the
mechanisms underlying the interaction between viral proteins and
membranes. In the present study, we report the binding and
interaction of a peptide corresponding to the second of the two
predicted amphipathic helices (peptide NS4BH2) and deﬁne it as a
new membrane association domain. We show that NS4BH2 strongly
partitions into phospholipid membranes, interacts with them, and is
located in a shallow position in the membrane. These results would
suggest that this NS4B element is an essential constituent of the
interaction between the protein and the membrane and might shed
light into the speciﬁc function of the NS4B protein in the viral cycle.
2. Materials and methods
2.1. Materials and reagents
Three sets of 37 peptides derived from HCV_1aH77 protein NS4B
(strictly speaking, NS4B spans from residue 1712 to residue 1972 of the
HCV polyprotein precursor) were obtained through the NIH AIDSHCV protein NS4B, assuming it forms anα-helical wheel [31]. The approximate functional
rane regions (TM) and two putative α-helices, H1 and NS4BH2. (B) Correlation of the HCV
ry onmodelmembranes composed of EPC/SM/Chol at a phospholipidmolar ratio of 5:1:1,
respectively). Vertical bars indicate standard deviations of the mean of triplicate samples.
udy, assuming they form an α-helix.
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Bethesda, MD). The synthetic peptide encompassing residues 1946–
1964 of HCV_1aH77 strain NS4B (1946ILSSLTVTQLLRRLHQWI1964)
(NS4BH2) and two scrambled versions QHSRLVSITLIRLQLLTW (SC1)
and LIRQLHSLTQSTWLVRLI (SC2) were synthesized with N-terminal
acetylation and C-terminal amidation on an automatic multiple syn-
thesizer (Genemed Synthesis, San Antonio, TX, USA). The peptideswere
puriﬁed by reverse-phase high-performance liquid chromatography
(Vydac C-8 column, 250×4.6 mm, ﬂow rate 1 ml/min, solvent A, 0.1%
triﬂuoroacetic acid, solvent B, 99.9 acetonitrile and 0.1% triﬂuoroacetic
acid) to N95% purity, and its composition and molecular mass were
conﬁrmed by amino acid analysis and mass spectroscopy. Since
triﬂuoroacetate has a strong infrared absorbance at approximately
1673 cm−1, which interferes with the characterization of the peptide
Amide I band [35], residual triﬂuoroacetic acid, used both in peptide
synthesis and in the high-performance liquid chromatography mobile
phase, was removed by several lyophilization/solubilization cycles in
10 mM HCl [36]. Peptide NS4BH2 was solubilized in water whereas
peptides SC1 and SC2 were solubilized in water/DMSO at 50% (v/v).
Bovine brain phosphatidylserine (BPS), bovine liver L-α-phospha-
tidylinositol (BPI), cholesterol (Chol), egg phosphatidic acid (EPA), egg
L-α-phosphatidylcholine (EPC), egg sphingomyelin (SM), egg trans-
esteriﬁed L-α-phosphatidylethanolamine (TPE), liver lipid extract,
tetramyristoyl cardiolipin (CL), 1,2-dimyristoylphosphatidylserine
(DMPS), 1,2-dimyristoylphosphatidylcholine (DMPC) and 1,2-dimyris-
toylphosphatidylglycerol (DMPG) were obtained from Avanti Polar
Lipids (Alabaster, AL, USA). The lipid composition of the synthetic
endoplasmic reticulum was EPC/CL/BPI/TPE/BPS/EPA/SM/Chol at a
molar ratio of 59:0.37:7.7:18:3.1:1.2:3.4:7.8 [37, 38]. 5-Carboxyﬂuores-
cein (CF, N95% by HPLC), 4-(2-(6-(Dioctylamino)-2-naphthalenyl)
ethenyl)-1-(3-sulfopropyl)-pyridinium inner salt (di-8-ANEPPS), ﬂuor-
escein isothiocyanate labeled dextrans (FD-10, FD-20 and FD-70,
deuterium oxide (99.9%), Triton X-100, EDTA and HEPES were
purchased from Sigma-Aldrich (Madrid, ES). 1,6-Diphenyl-1,3,5-hexa-
triene (DPH), and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-
hexatriene (TMA-DPH) were obtained fromMolecular Probes (Eugene,
OR). All other chemicals were commercial samples of the highest purity
available (Sigma-Aldrich, Madrid, ES). Water was deionized, twice-
distilled and passed through Milli-Q equipment (Millipore Ibérica,
Madrid, ES) to a resistivity higher than 18 MΩ cm.
2.2. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform–
methanol (2:1 vol/vol) were placed in a test tube, the solvents were
removed by evaporation under a stream of O2-free nitrogen, and
ﬁnally, traces of solvents were eliminated under vacuum in the dark
for N3 h. The lipid ﬁlms were resuspended in an appropriate buffer
and incubated either at 25 °C or 10 °C above the phase transition
temperature (Tm) with intermittent vortexing for 30 min to hydrate
the samples and obtain multilamellar vesicles (MLV). The samples
were frozen and thawed ﬁve times to ensure complete homogeniza-
tion and maximization of peptide/lipid contacts with occasional
vortexing. Large unilamellar vesicles (LUV) with a mean diameter of
0.1 μm (leakage measurements) and 0.2 μm (dextran release assays)
were prepared from MLV by the extrusion method [39] using
polycarbonate ﬁlters with a pore size of 0.1 and 0.2 μm (Nuclepore
Corp., Cambridge, CA, USA). Small unilamellar vesicles were prepared
from MLV using a Branson 250 soniﬁer (40 W) equipped with a
microtip until the suspension became completely transparent. Every
30 s, the samples were cooled for 90 s in ice to prevent overheating of
the solution. The titanium particles released from the tip were
removed by centrifugation at 15,000 rpm at room temperature for
15 min. For FTIR spectroscopy, aliquots containing the appropriate
amount of lipid in chloroform/methanol (2:1, v/v) was placed in a test
tube containing 200 μg of dried lyophilized peptide. After vortexing,the solvents were removed by evaporation under a stream of O2-free
nitrogen, and ﬁnally, traces of solvents were eliminated under vacuum
in the dark for more than 3 h. The samples were hydrated in 100 μl of
D2O buffer containing 20 mM HEPES, 100 mM NaCl, 0.1 mM EDTA, pH
7.4 and incubated at 10 °C above the phase transition temperature
(Tm) of the phospholipid mixture with intermittent vortexing for
45 min to hydrate the samples and obtain multilamellar vesicles
(MLV). The samples were frozen and thawed as above. Finally the
suspensions were centrifuged at 15,000 rpm at 25 °C for 15 min to
remove the possible peptide unbound to the membranes. The pellet
was resuspended in 25 μl of D2O buffer and incubated for 45 min at
10 °C above the Tm of the lipid mixture, unless stated otherwise. The
phospholipid and peptide concentration were measured by methods
described previously [40, 41].
2.3. Membrane leakage and peptide binding to vesicles
LUVs with a mean diameter of 0.1 μm were prepared as indicated
above in a buffer containing 10mM Tris, 20 mMNaCl, pH 7.4, and CF at
a concentration of 40 mM. Non-encapsulated CF was separated from
the vesicle suspension through a Sephadex G-75 ﬁltration column
(Pharmacia, Uppsala, SW, EU) eluted with buffer containing 10 mM
Tris, 100 mM NaCl, 1 mM EDTA, pH 7.4. Membrane rupture (leakage)
of intraliposomal CF was assayed by treating the probe-loaded
liposomes (ﬁnal lipid concentration, 0.125 mM) with the appropriate
amounts of peptide on microtiter plates using a microplate reader
(FLUOstar; BMG Labtech, Offenburg, Germany), stabilized at 25 °C
with the appropriate amounts of peptide, each well containing a ﬁnal
volume of 170 μl. The medium in the microtiter plates was
continuously stirred to allow the rapid mixing of peptide and vesicles.
In the case of LUVs (0.2 μm) encapsulated with ﬂuorescent dextrans
(FD10, FD20 or FD70) the lipid was resuspended to a concentration of
100 mg/ml solution of dextrans in a buffer containing 10 mM Tris,
100 mM NaCl, pH 7.4. Non-encapsulated dextrans were removed by
gel-ﬁltration chromatography using a pump P-50 (Amershan Phar-
macia Biotech AB, Uppsala, Sweden) with a Sephacryl® 500-HR
column eluted with the same buffer as described above, at a ﬂow rate
of 3 ml/min. The ﬁnal lipid concentration was 0.075 mM in a
5 mm×5 mm ﬂuorescence cuvette (ﬁnal volume of 400 μl), stabilized
at 25 °C and under constant stirring. The ﬂuorescence was measured
using a Varian Cary Eclipse spectroﬂuorimeter. Changes in ﬂuores-
cence intensity were recorded with excitation and emission wave-
lengths set at 492 and 517 nm, respectively. Excitation and emission
slits were set at 5 nm. Leakage was quantiﬁed on a percentage basis as
previously described [42,43]. Peptide partitioning into membranes
was evaluated by the enhancement of the tryptophan ﬂuorescence by
successive additions of small volumes of LUV to a peptide sample
(3.4×10−5 M). Fluorescence spectra were recorded in a SLM Aminco
8000C spectroﬂuorometer with excitation and emission wavelengths
of 290 and 348 nm, respectively, and 4 nm spectral bandwidths.
Measurements were carried out in 10 mM Tris, 100 mM NaCl, EDTA
0.1 mM, pH 7.4. Intensity values were corrected for dilution, and the
scatter contribution was derived from lipid titration of a vesicle blank.
The peptide concentration in the assays was 30 μm. The data were
analyzed as previously described [43].
2.4. Acrylamide quenching of Trp emission and steady-state ﬂuorescence
anisotropy
Aliquots from a 4 M solution of the water-soluble quencher were
added to the solution-containing peptide in the presence and absence
of liposomes at a peptide/lipid molar ratio of 1:70. The results
obtained were corrected for dilution and the scatter contribution was
derived from acrylamide titration of a vesicle blank. The data were
analyzed according to the Stern–Volmer equation [44]. Aliquots of
TMA-DPH or DPH in N,N′-dimethylformamide were directly added
Table 1
Result of the alignment (ClustalW) of residues 1712–1972 (1aH77 numbering) from
reference strains representing the major genotypes of Hepatitis C virus as well as the
NS4BH2 sequence examined in this work.
Genotype Virus strain Sequence
1a 1 ILSSLTVTQLLRRLHQWI
1a H ILSSLTVTQLLRRLHQWI
1b HC-J1 ILSSLTVTQLLRRLHQWL
1b HC-J4 ILSSLTITQLLKRLHQWI
4a ED43 ILSSLTVTSLLRRLHKWI
3a k3a LLSSLTVTSLLRRLHQWI
3k JK049 LLSSLTVTQLLRRLHQWI
5a SA13 LLSSLTVTSLLKRLHTWI
6a EUHK2 ILTSLTITSLLRRLHQWV
2a HC-J6 LLGSLTITSLLRRLHNWI
2a JFH-1 LLGSLTITSLLRRLHNWI
2b HC-JB VLSSLTITSLLRRLHAWI
NS4BH2 ILSSLTVTQLLRRLHQWI
Consensus :⁎ ⁎⁎⁎:⁎.⁎⁎:⁎⁎⁎ ⁎:
The consensus sequence is shown beneath the alignment.
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obtain a probe/lipid molar ratio of 1/500. Samples were incubated for
15 or 60 min when TMA-DPH or DPH were used, respectively, 10 °C
above the gel-to-liquid crystalline phase transition temperature Tm of
the phospholipid mixture. Afterwards, the peptides were added to
obtain a peptide/lipid molar ratio of 1:15 and incubated 10 °C above
the Tm of each lipid for 1 h, with occasional vortexing. All ﬂuorescence
studies were carried using 5 mm×5 mm quartz cuvettes in a ﬁnal
volume of 400 μl (315 μM lipid concentration). The steady-state
ﬂuorescence anisotropy was measured with an automated polariza-
tion accessory using a Varian Cary Eclipse ﬂuorescence spectrometer,
coupled to a Peltier for automatic temperature change. Samples were
excited at 360 nm (slit width, 5 nm) and ﬂuorescence emission was
recorded at 430 nm (slit width, 5 nm).
2.5. Differential scanning calorimetry
MLVs were formed as stated above in 20 mMHEPES, 100 mMNaCl,
0.1 mM EDTA, pH 7.4. The peptide was added to obtain a peptide/lipid
molar ratio of 1:15. The ﬁnal volume was 1.2 ml (0.5 mM lipid con-
centration), and incubated 10 °C above the Tm of each phospholipids
for 1 h with occasional vortexing. Samples were loaded into the
calorimetric cell. DSC experiments were performed in a VP-DSC
differential scanning calorimeter (MicroCal LLC, MA) under a constant
external pressure of 30 psi in order to avoid bubble formation, and
samples were heated at a constant scan rate of 60 °C/h. Experimental
data were corrected from small mismatches between the two cells by
subtracting a buffer baseline prior to data analysis. The excess heat
capacity functions were analyzed by using Origin 7.0 (Microcal
Software). The thermograms were deﬁned by the onset and comple-
tion temperatures of the transition peaks obtained from heating scans.
In order to avoid artifacts due to the thermal history of the sample, the
ﬁrst scanwas never considered; second and further scans were carried
out until a reproducible and reversible pattern was obtained.
2.6. Infrared spectroscopy
Infrared spectroscopy measurements were performed and analyzed
as described previously [42]. Two-dimensional correlation analysis was
carried out using the 2D-Shige programwritten by Shigeaki Morita and
Yukihiro Ozaki (Kwansei-Gakuin University, Japan; http://sci-tech.ksc.
kwansei.ac.jp/~ozaki/e_2D.htm). To obtain the 2D-infrared maps,
heatingwasused as theperturbation to induce time-dependent spectral
ﬂuctuations in the infrared spectra of DMPC/NS4B peptide and DMPG/
NS4B peptide complexes, so that to induce the phase transition of the
phospholipid membranes and observe any modulation of the con-
formation on the peptide induced by the phase change. Visualization of
the 2D-infrared maps was performed using Origin software (Microcal
Systems, Boulder, CO). The maximum and minimum intensities for the
whole correlationmapwere found, their values weremultiplied by two
and amaximum of thirty contour lines were drawn, so that the number
of contour lines reﬂects their intensities in relation to the main peak.
Since the synchronous spectrum is always required for the interpreta-
tion of intensity and width changes, and our interest aims to ﬁnd the
inter-molecular interactions between NS4B peptide and the phospho-
lipids molecules, we have used throughout this work the synchronous
2D-infrared correlation contour maps to analyze the data as it has been
done before [45].
2.7. Circular dichroism measurements
Circular dichroism spectra were recorded at 25 °C using a JASCO-
810 spectropolarimeter in a 2 mm path-length quartz cell. An external
bath circulator Neslab RTE-111, connected to the spectropolarimeter,
controlled the sample temperature.Wavelength spectrawere acquired
every 0.2 nm at a scan speed of 50 nmmin−1 with a response time of2 s and averaged over ﬁve scans from 250 to 190 nm, with a band
widthof 2 nm. Spectrawere corrected for theblank. Samples contained
6×10−5 M of peptide in 10 mM phosphate buffer at pH 7.4. Different
concentrations of TFE, DMPC and DMPG were added to the
corresponding peptide samples.
3. Results
The analysis of hydrophobicity, hydrophobic moments and inter-
facial hydrophobicity distribution along the NS4B sequence of
HCV_1aH77 strain, assuming an α-helix, is shown in Fig. 1A [31,46,47].
It is possible to observe the highly hydrophobic nature of the protein
since 4/5 transmembrane domains, corresponding with the TM
proposed domains, are easily apparent [21,25,26]. Furthermore, two
zones of highly hydrophobic character, corresponding with the
proposed H1 and H2 helices, can be discerned [28] (Fig. 1A). The three
dimensional structure of theNS4Bprotein is not known, but this analysis
renders to us the potential surface zones potentially implicated in the
modulation of membrane binding. Therefore, these regions could
mediate the interaction with similar domains of other HCV NS proteins
or with the membrane.
We have studied the effect of a HCV_1aH77 NS4B derived peptide
library onmembrane rupture bymonitoring leakage from two different
liposome compositions (Fig. 1B). The peptide library used in this study
and their correlation with the HCV NS4B protein sequence is also
depicted in Fig. 1B. Two and three consecutive peptides in the library
have an overlap of 11 and 4 amino acids, respectively. The lipidic com-
position of the model membranes was EPC/SM/Chol at a phospholipid
molar ratio of 5:1:1, and a complex lipid composition resembling the ER
membrane. When the NS4B derived peptide library was assayed on
liposomes, some exerted an important leakage effect (Fig.1B). However,
the most remarkable effect was observed for peptide encompassing
residues 1946–1964,whichproduced leakage values of 100%, on the two
speciﬁc lipid composition tested. Other peptides elicited leakage values
between 20 and 70%, but no onewas capable of producing 100% leakage
values as peptide 1946–1964 did. However, remarkable is the effect of
peptide 1891–1909 in ER membranes (peptide 1891–1909 would
correspond to a TM proposed domain) and peptide 1913–1929 in the
mixture of EPC/SM/Chol (peptide 1913–1929 would correspond to the
ﬁrst putative α-helix). It is interesting to note that peptide correspond-
ing to sequence 1946–1964 of the NS4B protein coincides with the
region where the predicted H2 helix resides (see above). As shown in
Table 1, this region is signiﬁcantly conserved among the major
genotypes of HCV. The conservation of this pattern across different
strains of HCV indicates that this sequence is likely to be an important
region in this protein. Taking into account these results, we performed
an in-depth study of peptide 1946–1964, i.e., peptide NS4BH2, as well as
Fig. 2. Change on the ﬂuorescence intensity (A and B) and steady-state anisotropy (C and D) of the Trp residue of the NS4BH2 peptide (A and C) and the two scrambled peptides
(B andD) in the presence of increasing lipid concentrations. The lipid compositions usedwere EPC/SM/CHOL at amolar ratio of 5:1:1) (□), EPC/TPE/CHOL at amolar ratio of 5:3:1 (◯),
synthetic ERmembranes (♦) EPC/CHOL at amolar ratio of 5:1, (▲for NS4BH2 and SC1 and△ for SC2) and EPC/BPS/CHOL at amolar ratio of 5:3:1 (■ for NS4BH2 and SC1 and□ for SC2).
To guide the eye empirical lines have been drawn in B, C and D.
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binding and interaction with different membrane model systems, as
well as characterized the structural changes taking place in both the
peptide and phospholipid molecules.
The ability of the NS4BH2 peptide to interact with membranes was
determined from ﬂuorescence studies of the peptide intrinsic Trp in
presence of model membranes [48] containing different phospholipid
compositions at different lipid/peptide ratios (Fig. 2). The Trp
ﬂuorescence intensity of the NS4BH2 peptide increased upon increasing
the lipid/peptide ratio, indicating a signiﬁcant change on the environ-Fig. 3. Effect on the carboxyﬂuorescein release of LUVs contents for different lipid compositio
used were EPC (●), EPC/CHOL at a molar ratio of 5:1 (▲), EPC/SM/CHOL at a molar ratio of 2
1:1:1 (▼), EPC/BPS/CHOL at a molar ratio of 5:3:1 (■), EPC/TPE/CHOL at a molar ratio of 5:
membranes (♦). (C) Effect of the NS4BH2 peptide on the release of ﬂuorescein-labeled dextr
Release of carboxyﬂuorescein is showed for comparison (▲).ment of the Trpmoiety of the peptide (Fig. 2A). However, when the two
scrambled peptides SC1 and SC2 were used, also differences were
observed since ﬂuorescence intensity increased but slightly in the case
of SC2 peptide, and in the presence of the negatively charged
phospholipid BPS (Fig. 2B). In the case of the NS4BH2 peptide, partition
constant (Kp) values in the range 105 were obtained for the different
phospholipid compositions studied, indicating that the peptide was
bound to the membrane surface with high afﬁnity [48–51]. The highest
Kp value, i.e., 8.5×105,was obtained for the sample containingEPC/BPS/
Chol at a molar ratio of 5:3:1 (Fig. 2A). In the presence of membranes,ns of the NS4BH2 peptide (A) and the SC1 and SC2 peptides (B). The lipid compositions
:1:1 (⋄), EPC/SM/CHOL at a molar ratio of 5:1:1 (□), EPC/SM/CHOL at a molar ratio of
3:1 (◯), EPA/CHOL at a molar ratio of 5:1 (△), lipidic liver extract (▽),and synthetic ER
ans, FD-10 (□), FD-20 (●) and FD-70 (△) from LUVs of EPC/Chol at a molar ratio of 5:1.
Fig. 4. Stern–Volmer plots for the quenching of the ﬂuorescence of the Trp residue of the (A) NS4BH2, (B) SC1 and (C) SC2 peptides by acrylamide. Peptides in buffer (◯) and in the
presence of LUVs composed of EPC/CHOL at a molar ratio of 5:1 (▲),EPC/BPS/CHOL at a molar ratio of 5:3:1 (■),EPC/TPE/CHOL at amolar ratio of 5:3:1 (◯),EPC/SM/CHOL at amolar
ratio of 5:1:1 (□) and synthetic ER membranes (♦).
Table 2
Acrylamide Stern–Volmer quenching constants (KSV) obtained from the ﬂuorescence of
the Trp residue of the NS4BH2, SC1 and SC2 peptides in buffer and in the presence of
different model membranes.
LUV compositions NS4BH2 SC1 SC2
EPC/SM/CHOL 5:1:1 2.74 – –
EPC/TPE/CHOL 5:3:1 3.04 – –
EPC/BPS/CHOL 5:3:1 2.75 9.86 3.73
EPC/CHOL 5:1 4.71 7.53 13.16
ER 4.83 – –
Peptide in buffer 18.19 13.15 26.03
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shift from350 to337nm(not shown). However, the emissionmaximum
of the SC1 peptide remained virtually unaltered at 345 nm and the
emissionmaximumwavelength of the SC2peptide changed from350 to
342 in the presence of the zwitterionic lipidic mixture EPC/Chol, and
from350 to 332 in thepresence of thenegatively charged lipidicmixture
EPC/BPS/Chol. Differences in the ﬂuorescence anisotropy values of the
peptides were also observed when in the presence of phospholipid
model membranes. It was found that addition of liposomes to the
NS4BH2 and SC2 (Fig. 2D) peptides increased signiﬁcantly the Trp
anisotropy values (Fig. 2C), being greater when negatively charged
phospholipids were used in the mixture for SC2 peptide. These results
indicate a decrease in the mobility of the Trp residue in these peptides.
However, peptide SC1 displayed a high, nearly constant, anisotropy
values, indicating, ﬁrst, a high degree of immobilization (oligomeriza-
tion/aggregation), even in the absence of membranes, and second, that
itwasnot bound to themembranes (Fig. 2D). Changes on themembrane
dipole potentialmagnitude elicited by NS4BH2wasmonitored bymeans
of the spectral shift of the ﬂuorescence probe di-8-ANEPPS [52–54]. In
the presence of the peptide, the greater decrease in the R450/520 value
was measured in the presence of negatively charged lipid compositions
(not shown for briefness), conﬁrming the presence of a speciﬁc
interaction of the peptide with vesicles bearing negatively charged
phospholipids, demonstrating that the peptidewas capable of inserting
into the lipid bilayer and modifying the dipole potential.
To explore the effect of the NS4BH2 peptide in the destabilization of
membrane vesicles, we studied its effect on the release of the
encapsulated ﬂuorophores CF, FD10, FD20 and FD70 (Stokes radius
around 6 Å, 23 Å, 33 Å and 60 Å, respectively) in model membranes
[55,56]. The extent of CF leakage observed at different peptide to lipid
molar ratios and the effect on different phospholipid compositions is
shown in Fig. 3A where it can be seen that the peptide was able to
induce the release of the internal contents of the liposomes in a dose-
dependent manner. It is interesting to note that the NS4BH2 peptide
induced a high percentage of leakage (80–90%), even at lipid/peptide
ratios as high as 200:1, for liposomes composed of EPC/Chol at amolar
ratio of 5:1, EPC/SM/Chol at a molar ratio of 5:1:1 and EPC (Fig. 3A).
Lower, but signiﬁcant, leakage values were obtained for liposomes
composed of EPC/BPS/Chol at a molar ratio of 5:3:1 and EPC/SM/Chol
at a molar ratio of 1:1:1 and 2:1:1 (at a lipid/peptide ratio of 200:1
leakage values were about 45–55%). Lower values were obtained for
liposomes composed of the synthetic ER membranes, EPC/TPE/Chol
at a molar ratio of 5:3:1, EPA/Chol at a molar ratio of 5:1 and a lipidic
liver extract. The leakage values observed for the scrambled peptides
SC1 and SC2 were much lower as observed in Fig. 2B. For liposomes
composed of EPC/BPS/Chol at a molar ratio of 5:3:1, EPC/Chol at amolar ratio of 5:1 and EPC/SM/Chol at a molar ratio of 5:1:1, leakage
values at lipid/peptide of 200:1 were about 45–60% for peptide SC2
and about 1–5% for peptide SC1, demonstrating that peptide NS4BH2
interacts more signiﬁcantly with liposomes than the scrambled
peptides SC1 and SC2. In order to characterize the pore size of the
pores which would be formed by the NS4BH2 peptide, we carried out a
series of experiments using FITC-dextrans of different sizes entrapped
in liposomes composed of EPC/Chol (Fig. 3C). As observed in the
ﬁgure, NS4BH2 was capable of inducing leakage of all ﬂuorophores,
albeit at different rates (the smaller the size, the higher the rate of
leakage). However, at the highest peptide/lipid ratio used, NS4BH2
was capable of releasing a signiﬁcant percentage of the dextrans
(between 70 and 90%) (Fig. 3C). The capacity of the NS4BH2 peptide to
induce the leakage of the dextrans but at a higher rate for lower size
ﬂuorophores and vice versa demonstrates that the NS4BH2 peptide is
capable of forming pores in the membrane but leading to a complete
disruption of the membrane [57,58].
To assess the accessibility of the Trp residue of the NS4BH2 peptide
to the aqueous environment before and after binding to membranes,
acrylamide, an efﬁcient water-soluble neutral quencher probe, was
used. Stern–Volmer plots for the quenching of Trp by acrylamide,
recorded in the absence and presence of lipid vesicles, are shown in
Fig. 4 and the resultant Stern–Volmer constants are presented in
Table 2. In aqueous solution the Trp residues were highly exposed to
the solvent that led to a more efﬁcient quenching. For the NS4BH2
peptide and in the presence of the phospholipid membranes, the
extent of quenching was signiﬁcantly reduced (from a KSV value of
18.19 M−1 in buffer to approximately 4.8–2.7 M−1 in the presence of
membranes). This data would indicate a very poor accessibility of the
Trp residues to the aqueous phase, consistent with the incorporation
of the peptide into the lipid bilayer. In the case of the scrambled
peptides different effects were observed (Fig. 4B and C). The SC1
peptide in solution gave a KSV of 13.15 M−1, suggesting a lesser
accessibility of the peptide Trp to the solvent than the NS4BH2 peptide
Fig. 5. Steady-state anisotropy, brN, of DPH (A, C, and E) and TMA-DPH (B, D and F) incorporated into (A and B) DMPC, (C and D) DMPG and (E and F) DMPS model membranes as a
function of temperature. Data correspond to vesicles containing pure phospholipid (◯) and phospholipid plus NS4BH2 peptide at a 15:1 molar ratio (●).
Fig. 6. DSC heating thermograms for liposomes of (A) DMPC and (B) DMPG in the presence (lower curves) and absence (upper curves) of the NS4BH2 peptide at a phospholipid/
peptide molar ratio of 15:1. All the thermograms are normalized to the same amount of lipid.
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Fig. 7. (A) Stacked infrared spectra in the Amide I′ region of the NS4BH2 peptide in solution (left) and in the presence of DMPC (middle) and DMPG (right) at different temperatures as indicated. (B) Infrared spectra of the scrambled peptides
SC1 (left) and SC2 (right) in the presence of DMPC at 35 °C. (C) Circular dichroism spectra of the NS4BH2 peptide in TFE (upper panel) and SUVs of DMPC and DMPG (middle and lower panels, respectively) at 25 °C. The percentages of TFE and
the lipid-to-peptide ratio are indicated. (D) Synchronous 2D-infrared contour maps in the CfO and Amide I′ regions of samples containing the NS4BH2 peptide in the presence of DMPC (upper panel) and DMPG (middle panel). The lower panel
show the 2D-infrared contour map of a sample containing the SC1 peptide in the presence of DMPC. The range of temperatures used for the generation of the 2D-infrared maps were 10–65 °C. The solid and dotted lines represent positive and
negative peaks, respectively. The phospholipid-to-peptide molar ratio was 15:1 in (A), (B) and (D).
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presence of liposomes composed of EPC/Chol and EPC/BPS/Chol, the
quenching of the Trp ﬂuorescence of NS4BH2 by acrylamide became
signiﬁcantly less efﬁcient (KSV values of 2.75 an 4.71 M−1, respec-
tively). However, KSV values for SC1 were higher (7.53 and 9.86 M−1,
respectively). The SC2 peptide yielded a KSV of 26.03 M−1 in buffer,
revealing a great accessibility to the solvent. However, the extent of
quenching was reduced but only in the presence of EPC/BPS/Chol
liposomes (KSV of 3.73 M−1) and not in the presence of EPC/Chol (KSV
of 13.16 M−1) (Table 2).
The effect of the NS4BH2 peptide on the structural and thermo-
tropic properties of phospholipid membranes was investigated by
measuring the steady-state ﬂuorescence anisotropy of the ﬂuorescent
probes DPH and TMA-DPH incorporated into model membranes
composed of saturated synthetic phospholipids as a function of
temperature (Fig. 5). For DMPC and DMPA bilayers, NS4BH2 decreased
the cooperativity of the thermal transition as well as induced an
increase of the anisotropy of both DPH and TMA-DPH above the Tm of
the phospholipids (Figs. 5A, B, C and D). In the case of DMPS, NS4BH2
decreased the cooperativity of the main gel-to-liquid transition but in
addition elicited a shift of about 3 °C to lower temperatures of the Tm
(Figs. 5E andF). NS4BH2, in general, was capable of decreasing the
cooperativity of the transition Tm for all phospholipids, as observed by
both types of probes. These results also suggest that the difference in
charge between the phospholipid head-groups affects, but slightly,
the peptide incorporation into the lipid bilayer, and therefore it should
be located at the lipid–water interface inﬂuencing the ﬂuidity of the
phospholipids [49].
The effect of the NS4BH2 peptide on the thermotropic phase
behavior of different phospholipid multilamellar vesicles was assayed
using differential scanning calorimetry (DSC) and the corresponding
proﬁles are shown in Fig. 6. Both DMPC and DMPG MLVs which have
not been extensively annealed at low temperatures display two
endothermic peaks on heating, the pre-transition (12–14 °C, Lβ′–Pβ′)
and the main transition (24 °C, Pβ′–Lα). As illustrated in Fig. 6, incor-
poration of NS4BH2 signiﬁcantly altered the thermotropic behavior of
both DMPC and DMPG, since the peptide abolished completely the
pre-transition of both phospholipids. At a lipid/peptide ratio of 15:1,
the main transition is apparently associated by at least two different
peaks, which should be due to mixed phases. The coexistence of at
least two phases would indicate that one of them would be enriched
in peptide (phospholipids highly disturbed) whereas the other one
would be impoverished in them (phospholipids slightly disturbed).
The existence of structural changes on the NS4BH2 peptide induced
by membrane binding was studied by analyzing the infrared Amide I′
band located between 1700 and 1600 cm−1 in membranes by infrared
spectroscopy (Fig. 7). The Amide I′ region of the fully hydrated peptide
in the buffer is shown in Fig. 7A. For the peptide in solution and at
low temperatures, the Amide I′ band was asymmetric with a
maximum of about 1648 cm−1 and two shoulders of about
1671 cm−1 and 1634 cm−1. The band with the intensity maximum
of about 1648 cm−1 would correspond to a mixture of unordered but
also helical structures, whereas the band with the intensity maximum
of about 1634 cm−1 would correspond to β-sheet [59,60]. AtTable 3
Secondary structure content of NS4BH2 peptide as determined by infrared spectroscopy in s
NS4BH2 peptide % Aggregated structures
(1610–1625 cm−1)
% α-helix/310-helix
(1650–1670 cm−1)
Buffer 15 °C 7 24
50 °C 39 14
+DMPC 15 °C 3 32
50 °C 2 37
+DMPG 15 °C 0 32
50 °C 0 46
The values are rounded off to the nearest integer.increasing temperatures, the band with a maximum of 1648 cm−1
decreased in intensity at the same time that two new bands at about
1682 cm−1 and 1616 cm−1 appeared (Fig. 7A). Since bands at about
1682 cm−1 and 1618 cm−1 appearing at the same time correspond to
aggregated structures, these data would imply that the NS4BH2
peptide changes from a mixture of helical, unordered and β-sheet
structures at low temperatures to a mixture of mainly aggregated
structures with small quantities of helical, β-sheet and unordered
structures at high temperatures. This is what is already observed by
band ﬁtting of the Amide I′ envelope of NS4BH2 peptide at two
temperatures (Table 3). Furthermore, this transitional change in
overall structure occurs at about 36–38 °C. In the presence of both
DMPC and DMPG and at all temperatures studied (Fig. 7A), the Amide
I′ envelope of the NS4BH2 peptide was related to that found for the
peptide in solution at low temperatures, suggesting a high degree of
conformational stability of the peptide but only in the presence of the
model membranes. The frequencies of the Amide I′ component bands
for NS4BH2 in the presence of both DMPC and DMPG were nearly
identical to those found for the peptide in solution, but their intensity
varied. As shown in Table 3, the peptide not only displayed high helical
content but also signiﬁcant unordered and β-sheet structures. These
results imply that the secondary structure of the NS4BH2 peptide is
affected by its binding to the membrane. For comparison, Fig. 7B
shows the Amide I′ band of peptides SC1 and SC2 in the presence of
DMPC at 35 °C, where a maximum of about 1616 cm−1 is observed
(the spectrawere nearly identical both at low and high temperatures).
These data demonstrates that these peptides are nearly completely
aggregated in the presence of membranes, in contrast to NS4BH2
which has a deﬁned structure. Similarly to infrared, CD spectra show
that the NS4BH2 peptide presents a relatively high content of helical
and unordered structures, but also β-sheet, in the presence of
increasing amounts of either TFE, DMPC or DMPG (Fig. 7C).
We have used two-dimensional infrared spectroscopy (2D-IR) in
order to get a deeper insight on the interaction between the NS4BH2
peptide and the phospholipids in the different samples. Since, as shown
above, there is one main transition at about 24 °C for both DMPC and
DMPG, we have obtained 2D-infrared correlation maps at one
temperature range, encompassing the gel-to-liquid crystalline phase
transition of the pure phospholipids (Fig. 7D). The synchronous 2D-
infrared correlation CfO and Amide I′ contour maps of NS4BH2 in the
presence of DMPC and DMPG are shown in the upper and middle
panels of Fig. 7D. Themost intense auto-peaks were located at 1647 and
1735 cm−1, indicating that these are the frequencies at which the main
changes should take place due to the interaction of the peptidewith the
phospholipids. The most intense cross-peak was observed at the same
frequencies (1647/1735 cm−1) and it was positive. These data indicate
that the major secondary structure of NS4BH2 which more signiﬁcantly
senses the phase transition of the phospholipids is the main secondary
structure elements of the peptide, i.e., the α-helix and unordered
components (band at 1647 cm−1). For comparison, the synchronous
2D-infrared correlation contour map of peptide SC1 in the presence of
DMPC is shown in the bottom panel of Fig. 7D. The map presents two
auto-peaks, an intense one located at 1735 cm−1 and a less intense
auto-peak at 1621 cm−1, aswell as a cross-peak at the same frequenciesolution and in the presence of phospholipids at different temperatures as indicated.
% β-sheet
(1625–1639 cm−1)
% random
(1640–1649 cm−1)
% β-turn
(1670–1690 cm−1)
39 21 10
30 15 17
28 24 12
24 27 10
32 22 14
17 20 17
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indicates that the degree of interaction between peptide SC1 and DMPC
is signiﬁcantly lower than that found for peptide NS4BH2 in the
presence of the same phospholipid, conﬁrming the data commented
above.
4. Discussion
The replication and assembly of HCV has been suggested to occur
in the ER or ER-derived membranes [7–9,61] where different proteins,
including NS4B, play a central role in viral particle formation and
budding. However, the functions of the individual proteins which
participate in replication and/or assembly remain poorly understood.
NS4B, a highly hydrophobic protein, has been suggested to alter ER
membranes so that the HCV replication complex can be formed and
therefore has a critical role in HCV formation. Since the biological roles
of NS4B can be modulated by membranes, using an approach similar
to that published recently [31–33], we have carried the analysis of the
membrane-active regions of NS4B by observing the effect of a NS4B-
derived peptide library from HCV strain 1aH77 on the integrity of
different membrane model systems.
We have been capable of discerning different regions along the
NS4B sequence which display distinct membranotropic properties
using a peptide library derived from the NS4B protein. Although the
use of peptide fragments might not fully mimic the properties of the
intact protein, our results give an indication of the relative propensity
of the different domains to bind, interact, and affect different model
membranes. When all the membrane leakage values were taken into
account, one peptide displayed signiﬁcant membrane rupture activity,
namely the region encompassing amino acids 1946–1964, peptide
NS4BH2 (Fig. 1B). Peptide NS4BH2 coincides with one of the predicted
amphipathic helices of the NS4B protein as stated above. The
importance of this region is demonstrated by the fact that mutations
in H2 abolish replication [23,29]. In this context, it is interesting to
note that mutation W1963S, which lies within the H2 region,
completely blocked replicon replication but did not alter the ability
of NS4B to induce membrane alterations when expressed as a GFP
fusion protein [29]. Consequently, we have made a comprehensive
study of a peptide derived from this region, NS4BH2, characterizing its
binding and interaction with model membrane systems.
Peptide NS4BH2 binds with high afﬁnity to phospholipid model
membranes, displaying similar binding afﬁnities as those found for
other peptides [48,49,51,62,63]. The peptide decreased the dipole
potential of the membrane as well. Binding of NS4BH2 to liposomes
was further demonstrated by hydrophilic quenching probes, since
NS4BH2 was less accessible for quenching by acrylamide implying a
buried location. An increase in Trp anisotropy was also observed for
NS4BH2 in the presence of phospholipidmodel membranes, showing a
signiﬁcant motional restriction. The fact that the two scrambled
peptides, as shown by the ﬂuorescence results, do not interact in the
same way with the membrane supports the importance of the
speciﬁcity on the primary amino acid sequence of this peptide. We
have also shown that the NS4BH2 peptide is capable of affecting the
steady-state ﬂuorescence anisotropy of ﬂuorescent probes located
into the palisade structure of the membrane, since the peptide was
capable of decreasing the mobility and cooperativity of the phospho-
lipid acyl chains when compared to the pure phospholipids. These
results suggest that the difference in charge between the phospholipid
head-groups affects, but slightly, the peptide incorporation into the
lipid bilayer. The peptide should be located at the lipid–water
interface inﬂuencing the ﬂuidity of the phospholipids, most probably
with an in-plane orientation rather than in a transmembrane position
(work in progress).
The NS4BH2 peptide was also capable of altering membrane
stability causing the release of ﬂuorescent probes, this effect being
dependent on lipid composition and on the lipid/peptide molar ratio.The highest CF release was observed for liposomes containing
zwitterionic phospholipids, although signiﬁcant leakage values were
also observed for liposomes composed of negatively charged phos-
pholipids. The speciﬁc disrupting effect should be due primarily to
hydrophobic interactions within the bilayer, although the speciﬁc
charge of the phospholipid head-groups affects, although slightly, the
extent of membrane leakage. NS4BH2 was also capable of releasing
bigger size molecules, although at smaller rates, implying that pores
might be formed in the membrane but leading to the complete
disruption of the membrane. Scrambled peptides induced membrane
leakage but to a lesser extent. All these data demonstrate that peptide
NS4BH2 interacts more signiﬁcantly with liposomes than the
scrambled peptides ones, implying a speciﬁc effect of the NS4BH2
sequence. Supposing that the solution structure is mainly an α-helix,
the charged residues are located in one spot of the helix, whereas the
non-polar ones are distributed uniformly along it (Fig. 1C).
The infrared spectra of the Amide I′ region of the fully hydrated
peptide in buffer changed signiﬁcantly with temperature. However, in
the presence of membranes, it did not change, demonstrating a high
stability of its conformation, where a mixture of α-helix, β-sheet and
random structures coexisted. These results imply that the secondary
structure of the NS4BH2 peptide is affected by its binding to the
membrane, so that membrane binding modulates the secondary
structure of the peptide as it has been suggested for other peptides
[48,49,51]. It should be recalled that aggregated structures were only
observed for the scrambled peptides in the presence of membranes.
This can be due to the change of the disposition of the charged amino
acids to locations where they disrupt the hydrophobic surface of the
peptide (see Fig. 1C). Interestingly, a speciﬁc interaction between
NS4BH2 and the phospholipid molecules was observed by 2D-IR.
Identifying regions within viral proteins is critical to understand
and characterize the infection process. The binding to the surface and
the modulation of the phospholipid biophysical properties which take
place when NS4BH2 is bound to the membrane, i.e., partitioning into
the membrane surface and perturbation of the bilayer architecture,
could be related to the conformational changes which might occur
during the biological activity of the NS4B protein. The conservation of
its structure as well as its physical and chemical properties should be
essential in its function, since changes in the primary sequence cause
the disruption of the hydrophobicity along the structure and prevent
the resulting peptide from interacting with the membrane. Therefore,
the NS4B region where the NS4BH2 peptide resides might have an
essential role in the membrane replication and/or assembly of the
viral particle through the modulation of the replication complex.
Consequently, our ﬁndings identify an important region in the HCV
NS4B protein which might be directly implicated in the HCV life cycle.
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